TRI-IMMUNOL LIQ IM
TRI-IMMUNOL LIQ IM
Discontinued
DIN Number
02019981
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
lederle labs, division of american cyanamid co
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02019981
AIG Number0313773002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AJ52 PERTUSSIS, PURIFIED ANTIGEN, COMB. WITH TOXOIDS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification80:08.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
DIPHTHERIA TOXOIDActive
Strength: 12.5 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID
PERTUSSIS VACCINEActive
Strength: 4 UNIT / 0.5 ML
Monograph: PERTUSSIS VACCINE
TETANUS TOXOIDActive
Strength: 5 LF / 0.5 ML
Monograph: TETANUS TOXOID